All COVID-19 articles – Page 12
-
NewsProtein may be the ‘glue’ that helps COVID virus stick
A study found that perlecan LG3 – a protein most commonly found in blood vessels and the brain – readily formed a stable bond with the COVID spike protein and perhaps enhanced the virus’ ability to bind with cells.
-
NewsInfants born to COVID-infected mums have triple risk of developing respiratory distress
Vaccinating mothers prior to infection significantly reduced the risk for full-term infants developing a breathing disorder that most often strikes premature newborns.
-
NewsStrong links found between long COVID and ME/CFS
People suffering from long COVID or Myalgic Encephalomyelitis /Chronic Fatigue Syndrome (ME/CFS) could benefit from a coordinated treatment strategy, a new study has found.
-
NewsScientists make COVID receptor protein in mouse cells
Initially motivated to make receptor-based sensors and therapies for COVID-19, scientists develop general strategy for producing other complex proteins.
-
NewsFIFA World Cup ends with win for Argentina - and COVID-19
The 2022 FIFA World Cup ended with a win for Argentina over France, but it was also a triumph for SARS-CoV-2 with a significant jump in the number of cases, some of which could have been prevented, a new study suggests.
-
NewsSpatial statistics experts warn that statistical proof of COVID-19 market theory is flawed
Huanan Seafood Wholesale Market in the Chinese city of Wuhan is not the only possible place of origin of the COVID-19 pandemic, a new study warns.
-
NewsHuman immune system evolves in the post-Omicron era
New research suggests that human immune responses are changing in order to combat the never-ending emergence of new SARS-CoV-2 variants.
-
NewsBlood analysis in patients finds characteristics of Long Covid
Analysis of blood samples from patients with Long Covid – a debilitating condition with unknown causes – has revealed serum protein changes as the likely culprit.
-
NewsSARS-CoV-2 can infect dopamine neurons, causing senescence
A new study has reported that SARS-CoV-2, the virus that causes COVID, can infect dopamine neurons in the brain and trigger senescence - when a cell loses the ability to grow and divide.
-
NewsNew study to examine very rare adverse events linked to COVID-19 vaccines
A multimillion-dollar global initiative will study causes and risk factors, to ensure safer vaccines are ready for the next potential pandemic.
-
NewsVaccine speeds up the production of antibodies against Covid
A new vaccine uses preexisting immunity to a separate virus (the influenza virus) to help kickstart the process of making antibodies against SARS-CoV-2.
-
NewsGenotyping technology detects Covid variants more quickly and cheaply than ever
A new study reveals that the technique detects new variants almost a week more quickly than traditional whole genome sequencing methods.
-
NewsGlowing COVID-19 diagnostic test prototype produces results in one minute
Researchers have unveiled a potential COVID-19 test inspired by bioluminescence. Using a molecule found in crustaceans, they have developed a rapid approach that detects SARS-CoV-2 protein comparably to one used in vaccine research.
-
NewsNonpharmaceutical interventions saved lives during COVID’s first wave, study shows
Research reveals that masking, shelter-in-place and other measures reduced growth rates of deaths, case numbers and hospitalizations in early 2020.
-
NewsCOVID-19 vaccine reduces long COVID in children
Researchers have found that vaccination of children provides moderate protection against long COVID. Vaccination also has a stronger effect in adolescents, who have a higher risk of developing long COVID than young children.
-
NewsFirst all-UK study of 67m people reveals consequences of missed COVID-19 vaccines
The first research study of the entire UK population highlights gaps in COVID-19 vaccine coverage. Between a third and a half of the population had not had the recommended number of COVID vaccinations and boosters by summer 2022.
-
NewsResaerchers design thermostable vaccine candidate for SARS-CoV-2 variants
Researchers report the design of a synthetic antigen that can be manufactured as a potential COVID-19 vaccine candidate - it is effective against all current strains of SARS-CoV-2 and can be quickly adapted for future variants as well.
-
NewsWastewater surveillance is key tool in keeping schools open during public health emergencies
The study focused on a middle and high school campus in Jefferson County, New York, serving 600 students, and compared results from wastewater surveillance to COVID-19 case trends.
-
NewsScientists discover how ultraviolet light degrades coronavirus
New research has revealed how light can be used to destroy infectious coronavirus particles that contaminate surfaces.
-
NewsNasal spray with antibodies could prevent COVID-19
Researchers have shown that nasal drops with IgA antibodies can protect mice from SARS-CoV-2 infection.
